KRUSE BO (EVP, CFO, Secy & Treas.) sold 1.9% of their position (4K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $110.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/5/2021ACC: 0001104659-21-135122
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-4K
Net shares
Net seller
$110.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$27.54
Trade value
$110.16K
% of position
1.9%
11/4/2021
213.08K→209.08K
Total
Net shares
−4K
Net value
-$110.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/4/2021 | S · Sale | −4K | $27.54 | $110.16K | 1.9% | 213.08K | 209.08K |
| Total | −4K | -$110.16K | ||||||
Derivative Transactions0
No derivative transactions reported